Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
PETQ or BSX: Which Is the Better Value Stock Right Now?
04:40pm, Friday, 02'nd Dec 2022 Zacks Investment Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
Boston Scientific's (BSX) New Buyout to Expand its Portfolio
04:10pm, Wednesday, 30'th Nov 2022 Zacks Investment Research
Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.
Boston Scientific's (BSX) New Buyout to Expand its Portfolio
12:47pm, Wednesday, 30'th Nov 2022
Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.
Investors Liked These 2 Stock Buyouts Tuesday
11:38pm, Tuesday, 29'th Nov 2022 The Motley Fool
Market performance was mixed as investors prepared for more insight on interest rates.
Investors Liked These 2 Stock Buyouts Tuesday
06:38pm, Tuesday, 29'th Nov 2022
Market performance was mixed as investors prepared for more insight on interest rates.
Stock investors should 'focus on the marathon, not the sprint'. Think S&P 500 at 6,000 by 2032, says BofA
02:27pm, Tuesday, 29'th Nov 2022 MarketWatch
Our call of the day comes from Bank of America, which tosses its own forecasts into a crowded ring, as they mix worries with encouragement about keeping an eye on the long-term prize.
Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham
12:00pm, Tuesday, 29'th Nov 2022
Boston Scientific Corp.'s BSX, +0.88% $615 million acquisition of Apollo Endosurgery Inc. APEN, +65.50% announced earlier is complementary to the former's endoscopy franchise, as it leverages its gast
Boston Scientific to acquire Apollo Endosurgery for $615 million in cash
07:13am, Tuesday, 29'th Nov 2022
Boston Scientific Corp. BSX, -0.82% said Tuesday it has agreed to acquire Apollo Endosurgery Inc. APEN, for $10 a share, or about $615 million in cash. The news sent Apollo's stock, which closed Monda
Boston Scientific (BSX) Posts Positive Post-Market Study Data
06:06pm, Monday, 28'th Nov 2022 Zacks Investment Research
The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.
Boston Scientific (BSX) Posts Positive Post-Market Study Data
02:17pm, Monday, 28'th Nov 2022
The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.
Why Is Boston Scientific (BSX) Up 5.6% Since Last Earnings Report?
04:31pm, Friday, 25'th Nov 2022 Zacks Investment Research
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Scotts Miracle-Gro, Walgreens Boots Alliance And 2 Other Stocks Insiders Are Selling
02:09pm, Tuesday, 22'nd Nov 2022 Benzinga
US crude oil futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s prosp
Final Trades: Salesforce, Amazon, Boston Scientific & more
05:36am, Saturday, 19'th Nov 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2022 Update
08:03am, Friday, 18'th Nov 2022 Seeking Alpha
Bridgewater Associates’ 13F portfolio value decreased from ~$23.60B to ~$19.75B this quarter. They increased Visa, Mondelez International, MasterCard, and Alphabet.
PETQ or BSX: Which Is the Better Value Stock Right Now?
04:40pm, Wednesday, 16'th Nov 2022 Zacks Investment Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
